Results 151 to 160 of about 58,465 (248)

Time-dependent modulation of muscarinic m1/m3 receptor signalling by local anaesthetics.

British Journal of Anaesthesia, 2014
S. Picardi, M. Stevens, K. Hahnenkamp, M. Durieux, Philipp Lirk, M. Hollmann   +5 more
semanticscholar   +1 more source

Targeting muscarinic receptors in schizophrenia treatment: Novel antipsychotic xanomeline/trospium chloride. [PDF]

World J Psychiatry
Pejčić AV.
europepmc   +1 more source

Antipsychotic drugs at 75: the past, present, and future of psychosis management. [PDF]

Br Med Bull
Lyman M, McCutcheon RA.
europepmc   +1 more source

Cholinergic system in schizophrenia: A systematic review and meta-analysis. [PDF]

Mol Psychiatry
Saint-Georges Z, MacDonald J, Al-Khalili R, Hamati R, Solmi M, Keshavan MS, Tuominen L, Guimond S.   +7 more
europepmc   +1 more source

Hypofractionated radiotherapy for breast cancer

, 2010
Bentzen, S.M., Haviland, J.S., Yarnold, J.R.   +2 more
core   +1 more source

Considerations for Augmenting Aripiprazole Long-Acting Injectables with Other Antipsychotics: A Mini-Review. [PDF]

Diseases
Shaw J, Kim E, Ton E, Lai C, Bota P, Allee T.   +5 more
europepmc   +1 more source

From theory to therapy: unlocking the potential of muscarinic receptor activation in schizophrenia with the dual M1/M4 muscarinic receptor agonist xanomeline and trospium chloride and insights from clinical trials. [PDF]

Int J Neuropsychopharmacol
Meyer JM, Kramer K, Vuocolo S, Kaul I, Miller AC.   +4 more
europepmc   +1 more source

Retraction: Induction of Hypoxia-inducible Factor 1 Activity by Muscarinic Acetylcholine Receptor Signaling. [PDF]

J Biol Chem
Hirota K, Fukuda R, Takabuchi S, Kizaka-Kondoh S, Adachi T, Fukuda K, Semenza GL.   +6 more
europepmc   +1 more source

The role of acetylcholine and its receptors in tumor immune regulation: mechanisms and potential therapeutic targets. [PDF]

Mol Cancer
Zhang C, Guo X, Wang Y, Zhang S, Wang Z.
europepmc   +1 more source

Allosteric modulation of the M1 muscarinic acetylcholine receptor: improving cognition and a potential treatment for schizophrenia and Alzheimer's disease.

Drug Discovery Today, 2013
B. Melancon, J. Tarr, Joseph D. Panarese, M. Wood, C. Lindsley   +4 more
semanticscholar   +1 more source